Cataracts.
94 million people are blind or visually impaired globally, and cataract is the most common cause of blindness worldwide. However, most cases of blindness are avoidable. Cataract is associated with dec...
Cytokines : Questions médicales fréquentes
Questions fréquentes et termes MeSH associés
Diagnostic 5
#1
Comment diagnostiquer une dysrégulation des cytokines ?
Des tests sanguins mesurant les niveaux de cytokines peuvent aider au diagnostic.
#2
Quels symptômes indiquent un déséquilibre des cytokines ?
Symptômes comme la fièvre, la fatigue et l'inflammation peuvent indiquer un déséquilibre.
#3
Les cytokines peuvent-elles être mesurées dans le liquide céphalorachidien ?
Oui, les cytokines peuvent être mesurées dans le liquide céphalorachidien pour des maladies neurologiques.
#4
Quels tests sont utilisés pour évaluer les cytokines ?
Les tests ELISA et les dosages multiplex sont couramment utilisés pour évaluer les cytokines.
#5
Peut-on utiliser des biomarqueurs pour diagnostiquer des maladies liées aux cytokines ?
Oui, certains biomarqueurs peuvent indiquer des maladies inflammatoires ou auto-immunes.
Symptômes 5
#1
Quels sont les symptômes d'une inflammation causée par des cytokines ?
Rougeur, chaleur, douleur et gonflement sont des symptômes d'inflammation due aux cytokines.
#2
Les cytokines peuvent-elles provoquer de la fièvre ?
Oui, certaines cytokines, comme l'interleukine-1, peuvent induire de la fièvre.
#3
Comment les cytokines affectent-elles l'appétit ?
Les cytokines pro-inflammatoires peuvent réduire l'appétit et provoquer une perte de poids.
#4
Les cytokines sont-elles impliquées dans la douleur chronique ?
Oui, les cytokines peuvent sensibiliser les neurones et contribuer à la douleur chronique.
#5
Quels symptômes sont associés aux cytokines dans les maladies auto-immunes ?
Fatigue, douleurs articulaires et éruptions cutanées sont fréquents dans les maladies auto-immunes.
Prévention 5
#1
Peut-on prévenir les maladies liées aux cytokines ?
Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir ces maladies.
#2
Les vaccins influencent-ils les cytokines ?
Oui, les vaccins peuvent moduler la réponse des cytokines pour renforcer l'immunité.
#3
Comment le stress affecte-t-il les cytokines ?
Le stress chronique peut augmenter la production de cytokines pro-inflammatoires.
#4
L'exercice physique influence-t-il les cytokines ?
Oui, l'exercice régulier peut réduire les niveaux de cytokines pro-inflammatoires.
#5
Les habitudes alimentaires affectent-elles les cytokines ?
Une alimentation riche en antioxydants peut réduire l'inflammation et les cytokines.
Traitements 5
#1
Comment traiter un excès de cytokines ?
Des médicaments anti-inflammatoires et des inhibiteurs de cytokines peuvent être utilisés.
#2
Les thérapies biologiques ciblent-elles les cytokines ?
Oui, les thérapies biologiques comme les anticorps monoclonaux ciblent des cytokines spécifiques.
#3
Quels médicaments réduisent l'inflammation liée aux cytokines ?
Les corticostéroïdes et les anti-inflammatoires non stéroïdiens (AINS) sont efficaces.
#4
Les cytokines peuvent-elles être utilisées en thérapie ?
Certaines cytokines sont utilisées en thérapie pour stimuler le système immunitaire.
#5
Comment les inhibiteurs de cytokines aident-ils dans les maladies ?
Ils bloquent l'action des cytokines pro-inflammatoires, réduisant ainsi l'inflammation.
Complications 5
#1
Quelles complications peuvent survenir avec un excès de cytokines ?
Un excès de cytokines peut entraîner des maladies auto-immunes et des syndromes inflammatoires.
#2
Les cytokines sont-elles liées à des maladies cardiovasculaires ?
Oui, des niveaux élevés de certaines cytokines sont associés à un risque accru de maladies cardiovasculaires.
#3
Comment les cytokines affectent-elles le cancer ?
Certaines cytokines peuvent favoriser la croissance tumorale et la métastase dans le cancer.
#4
Les cytokines peuvent-elles causer des troubles neurologiques ?
Oui, des cytokines pro-inflammatoires sont impliquées dans des troubles neurologiques comme la dépression.
#5
Quelles sont les complications des traitements ciblant les cytokines ?
Les traitements peuvent entraîner des infections et des réactions allergiques comme complications.
Facteurs de risque 5
#1
Quels facteurs augmentent le risque de déséquilibre des cytokines ?
L'obésité, le tabagisme et le stress chronique augmentent le risque de déséquilibre.
#2
Les infections influencent-elles les niveaux de cytokines ?
Oui, les infections peuvent stimuler la production de cytokines pro-inflammatoires.
#3
L'âge affecte-t-il la production de cytokines ?
Oui, la production de cytokines peut diminuer avec l'âge, affectant la réponse immunitaire.
#4
Les maladies chroniques influencent-elles les cytokines ?
Oui, des maladies comme le diabète et l'arthrite peuvent altérer la production de cytokines.
#5
Le mode de vie peut-il affecter les cytokines ?
Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter les niveaux de cytokines.
Contenu validé par Dr Olivier Menir
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/02/2025
Contenu vérifié selon les dernières recommandations médicales
Sous-catégories
115 au total
└─
Chimiokines
ChemokinesD018925 -
D23.529.374.200
└─
Facteurs de croissance hématopoïétique
Hematopoietic Cell Growth FactorsD016298 -
D23.529.374.410
└─
Facteur de croissance des hépatocytes
Hepatocyte Growth FactorD017228 -
D23.529.374.420
└─
Interférons
InterferonsD007372 -
D23.529.374.440
└─
Antagoniste du récepteur à l'interleukine-1
Interleukin 1 Receptor Antagonist ProteinD053590 -
D23.529.374.460
└─
Interleukines
InterleukinsD007378 -
D23.529.374.465
└─
Facteur inhibiteur de la leucémie
Leukemia Inhibitory FactorD053605 -
D23.529.374.470
└─
Lymphokines
LymphokinesD008222 -
D23.529.374.480
└─
Monokines
MonokinesD015846 -
D23.529.374.500
└─
Oncostatine M
Oncostatin MD053683 -
D23.529.374.562
└─
Ostéopontine
OsteopontinD053495 -
D23.529.374.625
└─
Lymphopoïétine stromale thymique
Thymic Stromal LymphopoietinD000094632 -
D23.529.374.656
└─
Facteurs de nécrose tumorale
Tumor Necrosis FactorsD048069 -
D23.529.374.750
└─└─
bêta-Thromboglobuline
beta-ThromboglobulinD001620 -
D23.529.374.200.070
└─└─
Chimiokines C
Chemokines, CD019744 -
D23.529.374.200.100
└─└─
Chimiokines CC
Chemokines, CCD019742 -
D23.529.374.200.110
└─└─
Chimiokines CXC
Chemokines, CXCD019743 -
D23.529.374.200.120
└─└─
Chimiokines CX3C
Chemokines, CX3CD020523 -
D23.529.374.200.130
└─└─
Protéines inflammatoires des macrophages
Macrophage Inflammatory ProteinsD019402 -
D23.529.374.200.600
└─└─
Facteurs de stimulation des colonies
Colony-Stimulating FactorsD003115 -
D23.529.374.410.240
└─└─
Facteur de croissance des cellules souches
Stem Cell FactorD019089 -
D23.529.374.410.800
└─└─
Interféron de type I
Interferon Type ID007370 -
D23.529.374.440.890
└─└─
Interféron lambda
Interferon LambdaD000095022 -
D23.529.374.440.946
└─└─
Interleukine-3
Interleukin-3D007377 -
D23.529.374.465.169
└─└─
Interleukine-4
Interleukin-4D015847 -
D23.529.374.465.186
└─└─
Interleukine-5
Interleukin-5D015848 -
D23.529.374.465.202
└─└─
Interleukine-6
Interleukin-6D015850 -
D23.529.374.465.224
└─└─
Interleukine-7
Interleukin-7D015851 -
D23.529.374.465.246
└─└─
Interleukine-8
Interleukin-8D016209 -
D23.529.374.465.312
└─└─
Interleukine-9
Interleukin-9D016906 -
D23.529.374.465.377
└─└─
Interleukine-10
Interleukin-10D016753 -
D23.529.374.465.510
└─└─
Interleukine-11
Interleukin-11D017370 -
D23.529.374.465.511
└─└─
Interleukine-12
Interleukin-12D018664 -
D23.529.374.465.512
└─└─
Interleukine-13
Interleukin-13D018793 -
D23.529.374.465.513
└─└─
Interleukine-15
Interleukin-15D019409 -
D23.529.374.465.515
└─└─
Interleukine-16
Interleukin-16D019410 -
D23.529.374.465.516
└─└─
Interleukine-17
Interleukin-17D020381 -
D23.529.374.465.517
└─└─
Interleukine-18
Interleukin-18D020382 -
D23.529.374.465.518
└─└─
Interleukine-23
Interleukin-23D053759 -
D23.529.374.465.550
└─└─
Interleukine-27
Interleukin-27D064094 -
D23.529.374.465.600
└─└─
Interleukine-33
Interleukin-33D000067596 -
D23.529.374.465.850
└─└─
Interleukine-2
Interleukin-2D007376 -
D23.529.374.480.372
└─└─
Facteurs inhibiteurs de la migration des leucocytes
Leukocyte Migration-Inhibitory FactorsD007961 -
D23.529.374.480.428
└─└─
Facteurs d'activation des macrophages
Macrophage-Activating FactorsD016215 -
D23.529.374.480.615
└─└─
Facteurs inhibiteurs de la migration des macrophages
Macrophage Migration-Inhibitory FactorsD008263 -
D23.529.374.480.625
└─└─
Facteurs suppresseurs immunologiques
Suppressor Factors, ImmunologicD013491 -
D23.529.374.480.700
└─└─
Facteur de transfert
Transfer FactorD014165 -
D23.529.374.480.750
└─└─
Interleukine-1
Interleukin-1D007375 -
D23.529.374.500.400
└─└─
Antigènes CD70
CD27 LigandD053282 -
D23.529.374.750.030
└─└─
Facteur d'activation des lymphocytes B
B-Cell Activating FactorD053264 -
D23.529.374.750.061
└─└─
Ligand de 4-1BB
4-1BB LigandD053330 -
D23.529.374.750.065
└─└─
Ligand de CD30
CD30 LigandD053285 -
D23.529.374.750.092
└─└─
Ligand de CD40
CD40 LigandD023201 -
D23.529.374.750.124
└─└─
Cytokine TWEAK
Cytokine TWEAKD000074049 -
D23.529.374.750.155
└─└─
Ectodysplasines
EctodysplasinsD053331 -
D23.529.374.750.186
└─└─
Ligand de Fas
Fas Ligand ProteinD053222 -
D23.529.374.750.249
└─└─
Lymphotoxine alpha
Lymphotoxin-alphaD008233 -
D23.529.374.750.500
└─└─
Hétérotrimère de lymphotoxines alpha1 bêta2
Lymphotoxin alpha1, beta2 HeterotrimerD053361 -
D23.529.374.750.505
└─└─
Lymphotoxine bêta
Lymphotoxin-betaD053308 -
D23.529.374.750.515
└─└─
Ligand de OX40
OX40 LigandD053278 -
D23.529.374.750.531
└─└─
Ligand de RANK
RANK LigandD053245 -
D23.529.374.750.562
└─└─
Ligand TRAIL
TNF-Related Apoptosis-Inducing LigandD053221 -
D23.529.374.750.625
└─└─
Facteur de nécrose tumorale alpha
Tumor Necrosis Factor-alphaD014409 -
D23.529.374.750.626
└─└─
Membre-13 de la superfamille du facteur de nécrose tumorale
Tumor Necrosis Factor Ligand Superfamily Member 13D053300 -
D23.529.374.750.656
└─└─
Membre-14 de la superfamille du facteur de nécrose tumorale
Tumor Necrosis Factor Ligand Superfamily Member 14D053326 -
D23.529.374.750.690
└─└─
Membre-15 de la superfamille du facteur de nécrose tumorale
Tumor Necrosis Factor Ligand Superfamily Member 15D053380 -
D23.529.374.750.710
└─└─└─
Chimiokine CCL1
Chemokine CCL1D054402 -
D23.529.374.200.110.050
└─└─└─
Chimiokine CCL26
Chemokine CCL26D000075906 -
D23.529.374.200.110.125
└─└─└─
Chimiokine CCL5
Chemokine CCL5D018946 -
D23.529.374.200.110.250
└─└─└─
Chimiokine CCL11
Chemokine CCL11D054413 -
D23.529.374.200.110.550
└─└─└─
Chimiokine CCL17
Chemokine CCL17D054414 -
D23.529.374.200.110.850
└─└─└─
Chimiokine CCL21
Chemokine CCL21D054421 -
D23.529.374.200.110.890
└─└─└─
Chimiokine CCL22
Chemokine CCL22D054422 -
D23.529.374.200.110.900
└─└─└─
Chimiokine CCL24
Chemokine CCL24D054423 -
D23.529.374.200.110.910
└─└─└─
Chimiokine CCL27
Chemokine CCL27D054425 -
D23.529.374.200.110.930
└─└─└─
Protéines chimioattractives monocytaires
Monocyte Chemoattractant ProteinsD018945 -
D23.529.374.200.110.990
└─└─└─
Chimiokine CXCL1
Chemokine CXCL1D054360 -
D23.529.374.200.120.050
└─└─└─
Chimiokine CXCL16
Chemokine CXCL16D000075743 -
D23.529.374.200.120.075
└─└─└─
Chimiokine CXCL5
Chemokine CXCL5D054365 -
D23.529.374.200.120.250
└─└─└─
Chimiokine CXCL6
Chemokine CXCL6D054427 -
D23.529.374.200.120.300
└─└─└─
Chimiokine CXCL9
Chemokine CXCL9D054370 -
D23.529.374.200.120.450
└─└─└─
Chimiokine CXCL10
Chemokine CXCL10D054357 -
D23.529.374.200.120.500
└─└─└─
Chimiokine CXCL11
Chemokine CXCL11D054371 -
D23.529.374.200.120.550
└─└─└─
Chimiokine CXCL12
Chemokine CXCL12D054377 -
D23.529.374.200.120.600
└─└─└─
Chimiokine CXCL13
Chemokine CXCL13D054382 -
D23.529.374.200.120.650
└─└─└─
Facteur-4 plaquettaire
Platelet Factor 4D010978 -
D23.529.374.200.120.900
└─└─└─
Chimiokine CX3CL1
Chemokine CX3CL1D054428 -
D23.529.374.200.130.500
└─└─└─
Chimiokine CCL18
Chemokine CCL18D000075366 -
D23.529.374.200.600.075
└─└─└─
Chimiokine CCL3
Chemokine CCL3D054405 -
D23.529.374.200.600.150
└─└─└─
Chimiokine CCL4
Chemokine CCL4D054407 -
D23.529.374.200.600.200
└─└─└─
Chimiokine CCL19
Chemokine CCL19D054415 -
D23.529.374.200.600.870
└─└─└─
Chimiokine CCL20
Chemokine CCL20D054418 -
D23.529.374.200.600.880
└─└─└─
Chimiokine CXCL2
Chemokine CXCL2D054426 -
D23.529.374.200.600.940
└─└─└─
Érythropoïétine
ErythropoietinD004921 -
D23.529.374.410.240.150
└─└─└─
Facteur de stimulation des colonies de granulocytes
Granulocyte Colony-Stimulating FactorD016179 -
D23.529.374.410.240.350
└─└─└─
Facteur de stimulation des colonies de granulocytes et de macrophages
Granulocyte-Macrophage Colony-Stimulating FactorD016178 -
D23.529.374.410.240.375
└─└─└─
Facteur de stimulation des colonies de macrophages
Macrophage Colony-Stimulating FactorD016173 -
D23.529.374.410.240.500
└─└─└─
Thrombopoïétine
ThrombopoietinD013926 -
D23.529.374.410.240.750
└─└─└─
Interféron alpha
Interferon-alphaD016898 -
D23.529.374.440.890.250
└─└─└─
Interféron bêta
Interferon-betaD016899 -
D23.529.374.440.890.275
└─└─└─
Sous-unité p35 de l'interleukine-12
Interleukin-12 Subunit p35D053765 -
D23.529.374.465.512.249
└─└─└─
Sous-unité p40 de l'interleukine-12
Interleukin-12 Subunit p40D053762 -
D23.529.374.465.550.249
└─└─└─
Sous-unité p19 de l'interleukine-23
Interleukin-23 Subunit p19D053760 -
D23.529.374.465.550.500
└─└─└─
Interféron gamma
Interferon-gammaD007371 -
D23.529.374.480.615.350
└─└─└─
Interleukine-1 alpha
Interleukin-1alphaD053582 -
D23.529.374.500.400.300
└─└─└─
Interleukine-1 bêta
Interleukin-1betaD053583 -
D23.529.374.500.400.600
└─└─└─└─
Chimiokine CCL2
Chemokine CCL2D018932 -
D23.529.374.200.110.990.500
└─└─└─└─
Chimiokine CCL7
Chemokine CCL7D054410 -
D23.529.374.200.110.990.750
└─└─└─└─
Chimiokine CCL8
Chemokine CCL8D054412 -
D23.529.374.200.110.990.875
└─└─└─└─
Époétine alfa
Epoetin AlfaD000068817 -
D23.529.374.410.240.150.750
└─└─└─└─
Filgrastim
FilgrastimD000069585 -
D23.529.374.410.240.350.500
└─└─└─└─
Lénograstim
LenograstimD000078224 -
D23.529.374.410.240.350.750
└─└─└─└─
Interféron alpha-2
Interferon alpha-2D000077190 -
D23.529.374.440.890.250.500
└─└─└─└─
Interféron bêta-1a
Interferon beta-1aD000068556 -
D23.529.374.440.890.275.500
└─└─└─└─
Interféron bêta-1b
Interferon beta-1bD000068576 -
D23.529.374.440.890.275.750
Auteurs principaux
Sara Assadiasl
2 publications dans cette catégorie
Affiliations :
- Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Cytokines" :
-
Cytokines in Liver Transplantation.
Cytokine 2021-09-24
-
Cytokines in Lung Transplantation.
Lung 2022-11-08
Mohammad Hossein Nicknam
2 publications dans cette catégorie
Affiliations :
- Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Immunology, Medical School, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: mhnicknam@sina.tums.ac.ir.
Publications dans "Cytokines" :
-
Cytokines in Liver Transplantation.
Cytokine 2021-09-24
-
Cytokines in Lung Transplantation.
Lung 2022-11-08
Edward M Behrens
1 publication dans cette catégorie
Affiliations :
- Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA. behrens@chop.edu.
Publications dans "Cytokines" :
-
Cytokines in Cytokine Storm Syndrome.
Advances in experimental medicine and biology
Allan E Stolarski
1 publication dans cette catégorie
Affiliations :
- Department of Surgery, Boston Medical Center, Boston University, Boston, Massachusetts.
- Department of Pathology and Laboratory Medicine, Boston University, Boston, Massachusetts.
Publications dans "Cytokines" :
-
Cytokine Drizzle-The Rationale for Abandoning "Cytokine Storm".
Shock (Augusta, Ga.)
Jiyoun Kim
1 publication dans cette catégorie
Affiliations :
- Department of Pathology and Laboratory Medicine, Boston University, Boston, Massachusetts.
Publications dans "Cytokines" :
-
Cytokine Drizzle-The Rationale for Abandoning "Cytokine Storm".
Shock (Augusta, Ga.)
Qiuyang Zhang
1 publication dans cette catégorie
Affiliations :
- Department of Pathology and Laboratory Medicine, Boston University, Boston, Massachusetts.
Publications dans "Cytokines" :
-
Cytokine Drizzle-The Rationale for Abandoning "Cytokine Storm".
Shock (Augusta, Ga.)
Daniel G Remick
1 publication dans cette catégorie
Affiliations :
- Department of Pathology and Laboratory Medicine, Boston University, Boston, Massachusetts.
Publications dans "Cytokines" :
-
Cytokine Drizzle-The Rationale for Abandoning "Cytokine Storm".
Shock (Augusta, Ga.)
Markus Brandhofer
1 publication dans cette catégorie
Affiliations :
- Division of Vascular Biology, Institute for Stroke and Dementia Research (ISD), Klinikum der Universität München (KUM), Ludwig-Maximilians-University (LMU), 81377 Munich, Germany.
Publications dans "Cytokines" :
-
Cytokine aerobics: Oxidation controls cytokine dynamics and function.
Structure (London, England : 1993)
Jürgen Bernhagen
1 publication dans cette catégorie
Affiliations :
- Division of Vascular Biology, Institute for Stroke and Dementia Research (ISD), Klinikum der Universität München (KUM), Ludwig-Maximilians-University (LMU), 81377 Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany; Munich Heart Alliance, 80802 Munich, Germany. Electronic address: juergen.bernhagen@med.uni-muenchen.de.
Publications dans "Cytokines" :
-
Cytokine aerobics: Oxidation controls cytokine dynamics and function.
Structure (London, England : 1993)
Camila Cataldi de Alcantara
1 publication dans cette catégorie
Affiliations :
- Research Laboratory in Applied Immunology, State University of Londrina, Paraná, Brazil.
Publications dans "Cytokines" :
-
Cytokines in psoriasis.
Advances in clinical chemistry 2020-05-23
Edna Maria Vissoci Reiche
1 publication dans cette catégorie
Affiliations :
- Research Laboratory in Applied Immunology, State University of Londrina, Paraná, Brazil; Department of Pathology, Clinical Analysis and Toxicology, State University of Londrina, Paraná, Brazil.
Publications dans "Cytokines" :
-
Cytokines in psoriasis.
Advances in clinical chemistry 2020-05-23
Andréa Name Colado Simão
1 publication dans cette catégorie
Affiliations :
- Research Laboratory in Applied Immunology, State University of Londrina, Paraná, Brazil; Department of Pathology, Clinical Analysis and Toxicology, State University of Londrina, Paraná, Brazil. Electronic address: deianame@yahoo.com.br.
Publications dans "Cytokines" :
-
Cytokines in psoriasis.
Advances in clinical chemistry 2020-05-23
Benjamin Amoani
1 publication dans cette catégorie
Affiliations :
- Department of Biomedical Science, College of Health Sciences, University of Cape Coast, Cape Coast, Ghana.
- Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Ghana.
- Molecular Medicine Department, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Ghana.
Publications dans "Cytokines" :
-
Cytokine profiles of
Cytokine: X 2019-10-04
Bright Adu
1 publication dans cette catégorie
Affiliations :
- Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Ghana.
Publications dans "Cytokines" :
-
Cytokine profiles of
Cytokine: X 2019-10-04
Margaret T Frempong
1 publication dans cette catégorie
Affiliations :
- Molecular Medicine Department, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Ghana.
Publications dans "Cytokines" :
-
Cytokine profiles of
Cytokine: X 2019-10-04
Tracy Sarkodie-Addo
1 publication dans cette catégorie
Affiliations :
- Department of Immunology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Ghana.
Publications dans "Cytokines" :
-
Cytokine profiles of
Cytokine: X 2019-10-04
Samuel Victor Nuvor
1 publication dans cette catégorie
Affiliations :
- Department of Microbiology, College of Health Sciences, University of Cape Coast, Cape Coast, Ghana.
Publications dans "Cytokines" :
-
Cytokine profiles of
Cytokine: X 2019-10-04
Emmanuel Kwasi Abu
1 publication dans cette catégorie
Affiliations :
- Department of Optometry, College of Health Sciences, University of Cape Coast, Cape Coast, Ghana.
Publications dans "Cytokines" :
-
Cytokine profiles of
Cytokine: X 2019-10-04
Lisa M Harrison
1 publication dans cette catégorie
Affiliations :
- Partnerships for Global Health, Department of Pediatrics, Yale School of Medicine, Yale University, New Haven, CT, USA.
Publications dans "Cytokines" :
-
Cytokine profiles of
Cytokine: X 2019-10-04
Michael Cappello
1 publication dans cette catégorie
Affiliations :
- Partnerships for Global Health, Department of Pediatrics, Yale School of Medicine, Yale University, New Haven, CT, USA.
Publications dans "Cytokines" :
-
Cytokine profiles of
Cytokine: X 2019-10-04
Sources (2027 au total)
Ontario Cataract Quality Outcome Initiative: appropriateness and prioritization of cataract surgery.
To explore the utility of the Catquest 9SF visual function (VF) questionnaire along with visual acuity (VA) for determining appropriateness and priority for cataract surgery. To evaluate the feasibili... Prospective multicentred interventional observational study.... Subjects undergoing sequential cataract surgery in both eyes at 4 sites in Ontario.... We recorded best-corrected VA (BCVA) and VA with current correction (CCVA) in each eye and both eyes (OU) and Catquest-9SF responses on a tablet before and after cataract surgery. Linear regression mo... Preoperative BCVA and CCVA in the worse eye were significant predictors of change in VF (p = 0.006 and p = 0.008, respectively); subjects with worse VA had a greater improvement in VF after surgery. T... For patient groups with equal VA, the Catquest-9SF score can help determine priority for surgery. Web-based data capture and interpretation allow for efficient virtual assessments of VF. A BCVA in the...
Outcomes of cataract surgery in children who present with cataract at uveitis diagnosis.
To describe the clinical and demographic characteristics of patients presenting with cataract at uveitis diagnosis treated at a single institution between 2005 and 2019 and to analyze postoperative ou... We retrospectively reviewed the medical records of children (<18 years of age) diagnosed with cataract at their initial uveitis presentation who subsequently underwent cataract extraction. Outcome mea... A total of 14 children (17 eyes) were included. Mean patient age was 7.2 ± 3.9 years. Methotrexate was initiated preoperatively in 11 patients; adalimumab, in 3. Primary intraocular lens was implanted... In our study cohort, surgery for preexisting cataract at uveitis diagnosis resulted in improved visual acuity. Postoperative uveitis flare-ups were relatively uncommon, occurring in 4 of 17 eyes. Glau...
Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery.
Cataract is the leading cause of blindness in the world and, as such, cataract surgery is one of the most commonly performed operations globally. Surgical techniques have changed dramatically over the... To compare the effectiveness and safety of FLACS with standard ultrasound phacoemulsification cataract surgery (PCS) by gathering evidence from randomised controlled trials (RCTs).... We searched the Cochrane Central Register of Controlled Trials (CENTRAL; which contains the Cochrane Eyes and Vision Trials Register; 2022, Issue 5); Ovid MEDLINE; Ovid Embase; LILACS; the ISRCTN regi... We included RCTs where FLACS was compared to PCS.... Three review authors independently screened the search results, assessed risk of bias and extracted data using the standard methodological procedures expected by Cochrane. The primary outcome for this... We included 42 RCTs conducted in Europe, North America, South America and Asia, which enrolled a total of 7298 eyes of 5831 adult participants. Overall, the studies were at unclear or high risk of bia...
Cataract surgery in patients with uveitis: Data from the Swedish National Cataract Register.
To investigate the surgical and pharmacological management and outcomes of patients with cataract and concurrent uveitis.... Data from the Swedish National Cataract Register, 2018-2019, were collected and analysed. Uveitic eyes were identified and eyes without uveitis were used as controls. Generalized estimating equations ... The study included 719 eyes with and 256 360 without uveitis. The mean age was 66.0 ± 13.5 (standard deviation [SD]) years in the uveitis group and 74.3 ± 8.7 years in the control group (p < 0.001). S... In this large registry-based Swedish cohort study, the findings demonstrate that cataract surgery in patients with uveitis poses more challenges and requires special surgical precautions. Eyes with co...
Risk factors affecting cataract surgery outcome: The Malaysian cataract surgery registry.
This is a 5 years multicentre database study that recruited subjects from the Malaysian Ministry of Health Cataract Surgery Registry (MOH CSR), aimed to determine risk factors that affect cataract sur...
Refractive Outcomes of Combined Cataract Surgery and Vitrectomy Compared to Cataract Surgery Alone.
The aim of the study was to evaluate the refractive outcomes of combined cataract surgery and vitrectomy compared to cataract surgery alone.... This retrospective chart review study included two groups: (1) combined surgery in 103 eyes (101 patients) who underwent cataract surgery with posterior chamber intraocular lens (PCIOL) placement by a... There was no statistically significant difference between predicted and actual postoperative refractive outcomes between the combined and cataract surgery alone groups (within ±0.5 diopters [D], p = 0... Combined cataract surgery and vitrectomy allows excellent refractive outcomes equal to cataract surgery alone, allowing each procedure to be performed independently by separate anterior and posterior ...
Assessing the cataract surgical rate and gender equity in cataract services in south-east Nigeria.
In 2020, almost 100 million people were blind or visually impaired from cataract. Cataract surgery is a cost-effective treatment for cataracts. In Nigeria, twice as many women are cataract blind as me... A retrospective review of cataract surgery undertaken in all eye health facilities in Imo State in 2019. Data collected included the type and location of facilities, patient demographics and the numbe... The CSR overall was 330/million and was slightly higher in women (347/million) than in men (315/million) (p<0.001). More elderly women (≥65 years) accessed cataract surgery through outreach than men a... The overall CSR in Imo state was approximately one-third of that recommended for sub-Saharan Africa. Although the CSR was higher in women than in men, considerably higher CSRs are needed in women to a...
Cataract, Cataract Surgery, and Risk of Incident Dementia: A Prospective Cohort Study of 300,823 Participants.
Visual impairment and interventions to preserve vision may impact dementia risk. Thus, we aimed to explore the associations of cataract and cataract surgery with the risk of dementia.... Prospective data from 300,823 individuals in the UK Biobank were used. We used multivariate Cox proportional hazards regression models to estimate hazard ratios (HRs) and 95% confidence intervals for ... After a mean follow-up of 8.4 years, 3226 individuals were diagnosed with dementia. The nonsurgical cataract group had increased risk of all-cause dementia (HR, 1.214; 95% CI, 1.012-1.456; p = .037) a... Cataract patients who did not receive surgical treatment had an increased risk of dementia. However, cataract surgery could reverse the risk of dementia. Our findings on brain structures and pathways ...
Developmental cataract in congenital ichthyosis.
A teenage boy who was previously diagnosed to have congenital ichthyosis presented to the eye clinic with complaints of gradually decreasing vision in both eyes since childhood. The best-corrected dis...